Jordan Ellis
As of June 2022, Hartford Hospital has performed 2,000 TAVR procedures, an alternative to open-heart surgery. TAVR is performed on patients with aortic stenosis and is less invasive, allowing patients to recover more quickly and go home after a shorter hospital stay.
| Characteristics | Values |
|---|---|
| Total TAVR procedures | 2,000 |
| Surgical risk | Approved by the FDA for most patients |
| Patient recovery time | 1-2 days |
| Alternative | Open-heart surgery |
Explore related products
What You'll Learn
TAVR is an alternative to open-heart surgery
Transcatheter Aortic Valve Replacement (TAVR) is a less invasive alternative to open-heart surgery. TAVR is performed by inserting a catheter through the groin to repair the aortic valve, whereas open-heart surgery involves a more invasive procedure with a longer recovery time.
TAVR offers several advantages over open-heart surgery. Firstly, it is a minimally invasive procedure, which means shorter recovery times and less time spent in the hospital. Patients who undergo TAVR often require minimal or no anaesthesia and can be discharged from the hospital as early as the next day. This is a significant improvement compared to the longer hospital stays typically associated with open-heart surgery.
Secondly, TAVR is a safe and effective treatment option for patients with aortic valve stenosis, a common heart problem affecting approximately 12% of people over the age of 65. Aortic valve stenosis is caused by a narrowing or hardening of the aortic valve due to calcium buildup, leading to severe symptoms such as shortness of breath, chest pain, fatigue, and fainting. Both TAVR and open-heart surgery have been found to restore patients' life expectancy to normal.
In terms of clinical outcomes, studies have shown comparable results between TAVR and open-heart surgery. The PARTNER 2A study, which involved more than 2,000 patients, compared the long-term outcomes of the two procedures. It found that after five years, both TAVR and open-heart surgery patients experienced similar improvements in disease-specific quality-of-life measures. Additionally, the rates of death and stroke were similar between the two groups, providing reassurance about the safety and effectiveness of TAVR.
While TAVR has gained popularity, it is important to note that there are still some long-term unknowns surrounding the procedure, especially for low-surgical-risk patients. As such, open-heart surgery remains a viable and important treatment option for aortic valve disease. However, TAVR provides a promising alternative for patients seeking a less invasive approach, and further research will help clarify its long-term benefits and applicability for different patient populations.
The Truth About August Alsina's Health: Dead or Alive?
You may want to see also
Explore related products
Patients recover quickly and are discharged within 1-2 days
TAVR, or Transcatheter Aortic Valve Replacement, is a less invasive alternative to open-heart surgery. The procedure is performed on patients with aortic stenosis and is now approved by the FDA for most patients, regardless of their surgical risk.
At Hartford Hospital, patients who undergo TAVR can expect a quick recovery. On average, patients are discharged from the hospital within 1 to 2 days following the procedure. This is significantly shorter than the recovery time associated with traditional open-heart surgery.
The expedited recovery time offered by TAVR at Hartford Hospital is attributed to the procedure's minimally invasive nature. As it does not require the surgical opening of the chest and heart, patients experience less trauma and discomfort, enabling them to heal faster.
The TAVR procedure at Hartford Hospital is performed by a dedicated and skilled team of cardiac surgeons, cardiologists, and other specialists who collaborate closely to ensure optimal patient care. The hospital's TAVR program is known for its multidisciplinary approach, with a Heart Team carefully evaluating each patient to determine the most suitable treatment option for them.
The quick recovery and discharge time associated with TAVR at Hartford Hospital is advantageous for patients, as they can return to the comfort of their homes sooner and resume their regular activities without prolonged hospitalization. This also helps free up hospital resources, making efficient use of time and space for other patients in need.
Cleveland Hospital: Esophageal Reconstruction Surgery Options
You may want to see also
It is FDA-approved for most patients
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive alternative to open-heart surgical valve replacement. TAVR has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with symptomatic aortic stenosis (AS) regardless of surgical risk. This includes patients who are at high or extreme risk for open-heart surgery. Aortic stenosis is the most common valvular heart disease requiring intervention in the United States, affecting approximately 165,000 low-risk patients per year.
The FDA's approval of TAVR for low-surgical-risk patients represents a paradigm shift in cardiology. It is the result of advances in research and clinical trials, which demonstrated excellent outcomes for low-risk patients treated with TAVR. The PARTNER 3 Trial, for example, found that low-risk patients treated with the Sapien 3 TAVR experienced low rates of death or disabling stroke, with 96% discharged to home or self-care. The FDA's approval of TAVR for low-risk patients was issued on August 16, 2019, and was the first regulatory body in the world to do so.
The approval of TAVR for low-risk patients expands access to this proven therapy and improves patient care. It allows physicians to offer TAVR as a preferred treatment option for a wider range of patients, including those who may be younger and more active than higher-risk patients. The availability of TAVR as a treatment option renews the focus on incorporating patient values and preferences in a shared decision-making approach. This includes considering the goals and priorities of low-risk patients, who may have different concerns than higher-risk patients.
The FDA's approval of TAVR for low-risk patients also highlights the importance of long-term follow-up and responsible use of the technology. Physicians are entrusted with the responsibility to ensure that TAVR is not abused and to monitor patients for an extended period to ensure that long-term outcomes are positive. This includes considering the specific needs and anatomies of individual patients to optimize flexibility, ease of tracking, and precision of valve placement. The approval of TAVR for low-risk patients is a significant development that expands treatment options and improves access to life-saving therapies.
Preventing Pressure Sores: Hospital Strategies for Patient Care
You may want to see also
A Heart Team evaluates patients for TAVR or traditional surgery
Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive procedure to repair a damaged heart valve by inserting a replacement without removing the old, damaged one. It is an alternative to open-heart surgery and is often used for patients with aortic stenosis.
A Heart Team is a specialized care team that evaluates patients for TAVR or traditional surgery. The team consists of interventional cardiologists, cardiothoracic surgeons, imaging specialists, advanced practitioners, and nurses. They carefully assess each patient to determine the best treatment option. This may include considering factors such as the patient's surgical risk, the extent of the disease, and the likelihood of a successful outcome with either treatment.
The Heart Team's evaluation process typically involves extensive testing and a comprehensive assessment of the patient's medical history, current health status, and individual needs. They may utilize advanced imaging techniques, such as transthoracic and transesophageal echocardiography, to visualize the aortic valve anatomy and make informed decisions.
In addition to the Heart Team, a multidisciplinary team is crucial for the TAVR procedure and subsequent care. This team includes skilled nurses, an interventional cardiologist specifically trained in TAVR, a cardiac surgeon, an echocardiographic imaging specialist, and a cardiac anesthesiologist if more than conscious sedation is required. Cardiac electrophysiologists, neurologists, nephrologists, and vascular surgeons are also part of the team, ready to address any potential complications.
As of 2022, Hartford Hospital in Connecticut has performed 2,000 successful TAVR procedures, becoming the first center in the state to reach this milestone. The hospital's Heart Team, comprising interventional cardiologists, cardiothoracic surgeons, imaging specialists, advanced practitioners, and nurses, plays a pivotal role in evaluating and treating patients with aortic stenosis.
Hospitals' PSA: What It Is and Why It Matters
You may want to see also
TAVR is performed on patients with aortic stenosis
Transcatheter Aortic Valve Replacement (TAVR), also referred to as transcatheter aortic valve implantation (TAVI), is a procedure that replaces a diseased aortic valve with a man-made valve. TAVR is performed on patients with aortic stenosis, a condition where the aortic valve is narrowed, restricting blood flow from the heart to the rest of the body. This procedure is suitable for patients who cannot tolerate traditional open-heart surgery due to a weaker heart, previous heart surgery, history of stroke, or other conditions that increase surgical risk.
During the TAVR procedure, a new valve is inserted without removing the old, damaged valve. This minimally invasive approach results in quicker recovery times, with patients typically staying in the hospital for one to two days. TAVR is performed under sedation and involves cardiac catheterization to evaluate the arteries supplying blood to the heart, as well as echocardiograms to assess the function of the new valve.
Hartford Hospital in Connecticut has been performing TAVR procedures since 2012 and achieved a milestone in 2022 by successfully completing 2,000 TAVR procedures, becoming the first center in the state to reach this number. The hospital's cardiac surgery and structural heart teams were recognised for their skill and commitment to excellence in cardiac care.
The decision to undergo TAVR is carefully evaluated by a Heart Team, including interventional cardiologists, cardiothoracic surgeons, imaging specialists, and other specialists. They assess each patient's unique circumstances to determine if TAVR is the most suitable treatment option. While TAVR has transformed the way patients with aortic stenosis are treated, it is still a major procedure with associated risks, including potential damage to blood vessels. Therefore, a comprehensive evaluation and personalised treatment plan are crucial to ensuring the best outcomes for each patient.
South Shore Hospital: A Medical School?
You may want to see also
Frequently asked questions
As of June 24, 2022, Hartford Hospital has performed 2,000 TAVR procedures.
TAVR (Transcatheter Aortic Valve Replacement) is an alternative to open-heart surgery for patients with aortic stenosis. It is a less invasive procedure that allows for quicker recovery and shorter hospital stays.
Not everyone is a candidate for TAVR. A Heart Team, including interventional cardiologists, cardiothoracic surgeons, and imaging specialists, carefully evaluates each patient to determine if they are better suited for traditional surgical aortic valve replacement or TAVR.
If you suffer from a diseased or congenitally malformed aortic valve, you can reach out to Hartford HealthCare at 860.901.1992 to explore your treatment options.
